TherapeuticsMD, Inc.
TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-04-0716:46 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001564590-23-005514 |
| 2023-04-0716:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-095317 |
| 2023-02-2716:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-050813 |
| 2023-01-1817:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-010258 |
| 2023-01-1217:01 ET | 8-K | 3.01 Delisting notice | 0001193125-23-007281 |
| 2023-01-0617:30 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-003686 |
| 2023-01-0307:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-000222 |
| 2022-12-0507:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-298002 |
| 2022-12-0109:23 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-22-296035 |
| 2022-11-1417:03 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001564590-22-037666 |
| 2022-11-1416:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-037633 |
| 2022-10-3107:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-273110 |
| 2022-10-0307:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-256102 |
| 2022-09-1207:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-242398 |
| 2022-08-3009:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-22-095856 |
| 2022-08-2917:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-232894 |
| 2022-08-1516:21 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-029490 |
| 2022-08-1507:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-029394 |
| 2022-08-0816:42 ET | SC 13D | Ownership report, active investor | 0001104659-22-087294 |
| 2022-08-0106:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-207645 |
| 2022-07-2908:58 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-22-205794 |
| 2022-07-2809:47 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-204332 |
| 2022-07-2508:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001193125-22-200476 |
| 2022-07-1409:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-193376 |
| 2022-06-0606:03 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001564590-22-022527 |
| 2022-06-0316:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001564590-22-022465 |
| 2022-05-3106:47 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-22-021755 |
| 2022-05-2010:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-22-020824 |
| 2022-05-1617:03 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-020440 |
| 2022-05-1616:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-020389 |
| 2022-05-0906:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001564590-22-018687 |
| 2022-04-2916:26 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001564590-22-016823 |
| 2022-04-2716:30 ET | 8-K | 8.01 Other events | 0001564590-22-016083 |
| 2022-04-2016:20 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 9.01 Financial statements and exhibits | 0001564590-22-014927 |
| 2022-04-1416:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-014472 |
| 2022-03-2316:54 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-011525 |
| 2022-03-2316:17 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-22-003889 |
| 2022-03-1817:01 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001564590-22-011090 |
| 2022-03-1007:15 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-009476 |
| 2022-03-0707:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-008860 |
| 2022-02-1816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-22-005710 |
| 2022-01-0306:03 ET | 8-K | 8.01 Other events | 0001564590-22-000008 |
| 2021-12-2008:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-060676 |
| 2021-12-1717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-060654 |
| 2021-12-1017:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-060036 |
| 2021-12-0806:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-059685 |
| 2021-11-1606:30 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-057142 |
| 2021-11-1206:55 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056434 |
| 2021-11-1206:47 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-056427 |
| 2021-10-0117:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-049852 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.